Evidence map›Paper›PMID 23014992›Full record

ReviewCellular and molecular life sciences : CMLS2013

Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

Xiaozhou He, Harleen K Sandhu, Yilin Yang, Fei Hua, Nathalee Belser, Dong H Kim, Ying Xia

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Electroacupuncture Ameliorates Cerebral I/R-Induced Inflammation through DOR-BDNF/TrkB Pathway.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  14. Article
  15. Review
  16. The Meta-Position of PheMolecules (Basel, Switzerland) · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Xiaozhou HeThe Third Clinical College of Suzhou University, Changzhou, Jiangsu, China.
Harleen K Sandhu
Yilin Yang
Fei Hua
Nathalee Belser
Dong H Kim
Ying Xia
The University of Texas at Austin · USSoochow University · CN

Funding

Hypoxia &Neuronal Excitability: Cellular MechanismsR01HD034852 · NICHD · YALE UNIVERSITY · PI XIA, YING · 1997 to 2012
$3.5M
A new strategy for protection from cerebral ischemiaR01AT004422 · NCCIH · YALE UNIVERSITY · PI XIA, YING · 2009 to 2013
$1.9M
NCCIH NIH HHS AT-004422NCCIH NIH HHS R01 AT004422NICHD NIH HHS HD-034852NICHD NIH HHS R01 HD034852
6 · The paper itself

Abstract

Hypoxic/ischemic injury remains the most dreaded cause of neurological disability and mortality. Despite the humbling experiences due to lack of promising therapy, our understanding of the complex cascades underlying the neuronal insult has led to advances in basic science research. One of the most noteworthy has been the effect of opioid receptors, especially the delta-opioid receptor (DOR), on hypoxic/ischemic neurons. Our recent studies, and those of others worldwide, present strong evidence that sheds light on DOR-mediated neuroprotection in the brain, especially in the cortex. The mechanisms of DOR neuroprotection are broadly categorized as: (1) stabilization of the ionic homeostasis, (2) inhibition of excitatory transmitter release, (3) attenuation of disrupted neuronal transmission, (4) increase in antioxidant capacity, (5) regulation of intracellular pathways-inhibition of apoptotic signals and activation of pro-survival signaling, (6) regulation of specific gene and protein expression, and (7) up-regulation of endogenous opioid release and/or DOR expression. Depending upon the severity and duration of hypoxic/ischemic insult, the release of endogenous opioids and DOR expression are regulated in response to the stress, and DOR signaling acts at multiple levels to confer neuronal tolerance to harmful insult. The phenomenon of DOR neuroprotection offers a potential clue for a promising target that may have significant clinical implications in our quest for neurotherapeutics.

Indexed as

Cell HypoxiaHumansModels, BiologicalNervous System DiseasesNeuroprotective AgentsReceptors, Opioid, deltaStress, PhysiologicalUp-RegulationNeuroprotective AgentsReceptors, Opioid, delta

Identifiers

PMID23014992
PMCPMC11113157
OpenAlexW2030181603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.